Michelle Walker

1.6k total citations
16 papers, 616 citations indexed

About

Michelle Walker is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Michelle Walker has authored 16 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Michelle Walker's work include Hepatitis C virus research (6 papers), Biochemical and Molecular Research (5 papers) and HIV/AIDS drug development and treatment (4 papers). Michelle Walker is often cited by papers focused on Hepatitis C virus research (6 papers), Biochemical and Molecular Research (5 papers) and HIV/AIDS drug development and treatment (4 papers). Michelle Walker collaborates with scholars based in United States and Norway. Michelle Walker's co-authors include Zhi Hong, Weidong Zhong, Nanhua Yao, Johnson Y.N. Lau, Craig E. Cameron, Christian Castro, W. Ian Lipkin, Zhi Hong, Jae Hoon Shim and Yan‐Jang S. Huang and has published in prestigious journals such as Annals of Neurology, Journal of Virology and Scientific Reports.

In The Last Decade

Michelle Walker

16 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Walker United States 13 302 285 235 150 133 16 616
Andrew Tuplin United Kingdom 18 271 0.9× 274 1.0× 325 1.4× 342 2.3× 246 1.8× 27 909
Sandra Sparacio Germany 7 183 0.6× 135 0.5× 143 0.6× 95 0.6× 199 1.5× 8 458
Pascal Mutz Germany 11 248 0.8× 365 1.3× 268 1.1× 150 1.0× 77 0.6× 20 713
Tomoko Kiyohara Japan 17 233 0.8× 448 1.6× 569 2.4× 124 0.8× 25 0.2× 35 837
Hong Thai United States 9 255 0.8× 355 1.2× 245 1.0× 168 1.1× 68 0.5× 23 721
Reinhard Glueck Switzerland 12 172 0.6× 316 1.1× 87 0.4× 73 0.5× 72 0.5× 19 485
Marcy E. Armstrong United States 8 155 0.5× 318 1.1× 106 0.5× 132 0.9× 31 0.2× 8 468
Richard W. Hardy United States 8 317 1.0× 323 1.1× 64 0.3× 105 0.7× 179 1.3× 10 639
Damir García‐Cehic Spain 13 227 0.8× 174 0.6× 195 0.8× 99 0.7× 28 0.2× 33 455
María Guadalupe Martínez France 14 264 0.9× 276 1.0× 156 0.7× 175 1.2× 117 0.9× 24 630

Countries citing papers authored by Michelle Walker

Since Specialization
Citations

This map shows the geographic impact of Michelle Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Walker more than expected).

Fields of papers citing papers by Michelle Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Walker. The network helps show where Michelle Walker may publish in the future.

Co-authorship network of co-authors of Michelle Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Walker. A scholar is included among the top collaborators of Michelle Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Walker. Michelle Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Walker, Michelle, David C. Metz, Charles A. Stanley, et al.. (2022). Case presentation of 8-year follow up of recurrent malignant duodenal Insulinoma and lymph node metastases and literature review of malignant Insulinoma management. BMC Endocrine Disorders. 22(1). 310–310. 3 indexed citations
2.
Patel, Nita, Jing-Hui Tian, Rhonda Flores, et al.. (2020). Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity. Vaccines. 8(4). 607–607. 20 indexed citations
3.
Cao, Dianjun, Yanyan Ni, Michelle Walker, Yao‐Wei Huang, & Xiang‐Jin Meng. (2018). Roles of the genomic sequence surrounding the stem‐loop structure in the junction region including the 3′ terminus of open reading frame 1 in hepatitis E virus replication. Journal of Medical Virology. 90(9). 1524–1531. 7 indexed citations
4.
George, Jeffy, Mary J. Mattapallil, Michelle Walker, et al.. (2017). Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques. Scientific Reports. 7(1). 10498–10498. 114 indexed citations
5.
Surendran, Naveen, Nammalwar Sriranganathan, Stephen M. Boyle, et al.. (2013). Protection to respiratory challenge of Brucella abortus strain 2308 in the lung. Vaccine. 31(38). 4103–4110. 17 indexed citations
6.
Walker, Michelle, Wen Xu, Jae Hoon Shim, et al.. (2006). Novel Nonnucleoside Inhibitors That Select Nucleoside Inhibitor Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Antimicrobial Agents and Chemotherapy. 50(8). 2772–2781. 38 indexed citations
7.
Wu, Jim Zhen, Nanhua Yao, Michelle Walker, & Zhi Hong. (2005). Recent Advances in Discovery and Development of Promising Therapeutics against Hepatitis C Virus NS5B RNA-Dependent RNA Polymerase. Mini-Reviews in Medicinal Chemistry. 5(12). 1103–1112. 25 indexed citations
8.
Walker, Michelle, Nanhua Yao, & Zhi Hong. (2003). Promising candidates for the treatment of chronic hepatitis C. Expert Opinion on Investigational Drugs. 12(8). 1269–1280. 15 indexed citations
9.
Walker, Michelle, T.C. Appleby, Weidong Zhong, Johnson Y. N. Lau, & Zhi Hong. (2003). Hepatitis C Virus Therapies: Current Treatments, Targets and Future Perspectives. Antiviral chemistry & chemotherapy. 14(1). 1–21. 41 indexed citations
10.
Cheney, I. Wayne, Vicky C. H. Lai, Michelle Walker, et al.. (2002). Mutations in NS5B Polymerase of Hepatitis C Virus: Impacts on in Vitro Enzymatic Activity and Viral RNA Replication in the Subgenomic Replicon Cell Culture. Virology. 297(2). 298–306. 44 indexed citations
11.
Walker, Michelle. (2002). HCV RNA-dependent RNA polymerase as a target for antiviral development. Current Opinion in Pharmacology. 2(5). 534–540. 39 indexed citations
12.
Walker, Michelle & W. Ian Lipkin. (2002). Characterization of the Nuclear Localization Signal of the Borna Disease Virus Polymerase. Journal of Virology. 76(16). 8460–8467. 14 indexed citations
13.
Hong, Zhi, Craig E. Cameron, Michelle Walker, et al.. (2001). A Novel Mechanism to Ensure Terminal Initiation by Hepatitis C Virus NS5B Polymerase. Virology. 285(1). 6–11. 164 indexed citations
14.
Walker, Michelle, Robert Schlaberg, Arthur P. Hays, Robert Bowser, & W. Ian Lipkin. (2001). Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients. Annals of Neurology. 49(2). 249–253. 3 indexed citations
15.
Walker, Michelle, Robert Schlaberg, Arthur P. Hays, Robert Bowser, & W. Ian Lipkin. (2001). Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients. Annals of Neurology. 49(2). 249–253. 35 indexed citations
16.
Walker, Michelle, Ingo Jordan, Thomas Briese, Nicole Fischer, & W. Ian Lipkin. (2000). Expression and Characterization of the Borna Disease Virus Polymerase. Journal of Virology. 74(9). 4425–4428. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026